Amyris Inc (AMRS) 0.34 $AMRS Amyris to Announce Second

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Amyris Inc (AMRS) 0.34 $AMRS

Amyris to Announce Second Quarter Financial Results on Thursday, August 4, 2016
GlobeNewswire - Mon Jul 18, 9:30AM CDT
Amyris, Inc. (Nasdaq:AMRS) will report financial results for the second quarter ended June 30, 2016 after market close on Thursday, August 4, 2016.
AMRS: 0.34 (-0.01)

Amyris Fuels First Delivery of New Airbus A350-900 Airplane for Cathay Pacific as Part of Two-Year Biojet Agreement
GlobeNewswire - Mon Jun 13, 7:30AM CDT
Amyris, Inc. (Nasdaq:AMRS), the industrial bioscience company, today announced that, on May 29, 2016, Cathay Pacific commenced a two-year program of flights from Toulouse to Hong Kong using Amyris renewable jet fuel. The initial 12-hour flight was the longest flight using a renewable jet fuel to date, further underpinning the 'drop-in' characteristics of Amyris Biojet fuels. Cathay took delivery of a new Airbus A350-900 that flew from the Airbus facility in Toulouse, France, to Hong Kong using a 10% biofuel jet blend provided by Amyris with the commercial and industrial support of Total S.A. The combination of the new airplane's improvements in fuel efficiency (about 25% better than current aircraft) and the fuel's properties resulted in an estimated 30% reduction in CO2 emissions according to Cathay when compared to comparable flights in recent-generation aircraft using fossil fuels. All of Cathay's upcoming A350-900 aircraft deliveries over the next two years will use the Amyris/Total Biojet fuel.
AMRS: 0.34 (-0.01)

Amyris Announces Collaboration with Johnson & Johnson Innovation for Biosynthetic Drug Discovery
GlobeNewswire - Mon Jun 06, 7:30AM CDT
Amyris's uPharm Platform to be Used for Rapid Integrated Discovery and Production of Therapeutic Compounds
AMRS: 0.34 (-0.01)

Gen9 and Amyris Announce Supply Agreement for Synthetic DNA
BusinessWire - Thu Jun 02, 8:00AM CDT
Gen9 and Amyris today announced an agreement for the supply of multiple megabases of synthetic DNA content. The DNA is being supplied for use in Amyris, Inc.'s (Nasdaq: AMRS) microbial engineering pipeline for the development of products that improve performance and enable sustainable growth for some of the world's leading brands. The collaboration is part of Gen9's MAP program, fueled by the BioFab(R) DNA synthesis technology, which provides valuable, high-quality synthetic DNA constructs for industrial-scale use.
AMRS: 0.34 (-0.01)

Amyris to Participate in June 2016 Investor Conferences
GlobeNewswire - Fri May 27, 7:30AM CDT
Amyris, Inc. (Nasdaq:AMRS), the industrial bioscience company, today announced that it plans to participate in the following upcoming investor conferences in June 2016 and provide an update on new partnerships and growth opportunities as part of its business plan for the year.
AMRS: 0.34 (-0.01)

Amyris & CJ CheilJedang Corporation Creating Manufacturing and Sales Partnership
GlobeNewswire - Fri May 20, 7:30AM CDT
Amyris, Inc. (Nasdaq:AMRS), the industrial bioscience company, and South Korea-based CJ CheilJedang Corporation ("CJ"(KRX:097950), today announced that the companies have signed a Memorandum of Understanding (MOU) to support large-scale manufacturing of Amyris's farnesene in existing CJ facilities. The arrangement described in the MOU would enable Amyris to utilize CJ's state of the art manufacturing capacity while minimizing the capital investment necessary to support projected near- and mid-term demand for product applications using farnesene. The partnership is also expected to include the opportunity for CJ Bio (division of CJ CheilJedang) to market select Amyris products in Asian markets as well as the potential for Amyris to develop several products for CJ Bio. The companies are targeting completing a definitive agreement by the first week of August 2016.
AMRS: 0.34 (-0.01)

Amyris to Participate in Upcoming Investor Conferences in May 2016
GlobeNewswire - Wed May 11, 1:42PM CDT
Amyris, Inc. (Nasdaq:AMRS), the industrial bioscience company, today announced that it plans to participate in the following upcoming investor conferences in May 2016.
AMRS: 0.34 (-0.01)

Amyris reports 1Q loss
Automated Insights - Tue May 10, 6:32PM CDT
EMERYVILLE, Calif. (AP) _ Amyris Inc. (AMRS) on Tuesday reported a loss of $15.3 million in its first quarter.
AMRS: 0.34 (-0.01)

Amyris First Quarter 2016 Results Deliver Strong Renewable Product Sales Growth and Continued Reduction in Operating Expenses
GlobeNewswire - Tue May 10, 4:09PM CDT
-- Q1 2016 revenues of $8.8 million, including product sales growth of 50% over Q1 2015
AMRS: 0.34 (-0.01)

Biossance(TM) Announces the Blacklist - 2,000+ Potentially Harmful Cosmetic Ingredients it Refuses to Use while Delivering Products Consumers Love to Use
GlobeNewswire - Fri May 06, 7:30AM CDT
Biossance(TM), the pioneer of sustainable solutions in beauty from Amyris, Inc. (Nasdaq:AMRS), announced today the Blacklist - 2,000+ common cosmetic ingredients it refuses to use due to safety and environmental concerns. The regulatory environment in the U.S. affords cosmetic brands the opportunity to use potentially harmful ingredients in cosmetic products. Biossance has created higher standards by adopting rigorous ingredient selection guidelines and omitting ingredients that are potentially harmful to you or the planet.
AMRS: 0.34 (-0.01)

Amyris to Announce First Quarter Financial Results on Tuesday, May 10, 2016
GlobeNewswire - Fri Apr 29, 7:30AM CDT
Amyris, Inc. (Nasdaq:AMRS) will report financial results for the first quarter ended March 31, 2016 after market close on Tuesday, May 10, 2016.
AMRS: 0.34 (-0.01)

Why Amyris Inc.'s Shares Spiked 34% Today
Travis Hoium, The Motley Fool - Motley Fool - Wed Apr 27, 12:20PM CDT
Image source: Amyris. What: Shares of Amyris Inc. jumped as much as 34% in early trading today after announcing a major supply agreement. But by midday on Wall Street, shares had settled to a more muted 7% gain. So what: Amyris said it...
AMRS: 0.34 (-0.01)

Top Stocks: Four Actively Traded Stocks on Wednesday April 27, 2016
ACCESSWIRE - Wed Apr 27, 11:35AM CDT
MIAMI, FL / ACCESSWIRE / April 27, 2016 / Top Nasdaq Stocks is issuing a report on four stocks to watch. MWOG, AMRS, LGCY, and ORIG have been added to our watch list today. Continue reading to find out why. - To get daily alerts on top stocks on the Nasdaq/NYSE subscribe to our newsletter at TopNasdaqStocks.com.
LGCY: 1.67 (-0.06), AMRS: 0.34 (-0.01), ORIG: 1.80 (-0.15)

Small Cap Watch: These 4 Stocks Are Making Big Moves Today
ACCESSWIRE - Wed Apr 27, 9:17AM CDT
NEW YORK, NY / ACCESSWIRE / April 27, 2016 / The Stock Expert is issuing a report on four stocks that are performing well this Tuesday. SRPT, LGCY, ORIG and AMRS are on high volume alert. Continue reading to find out why. - To get daily alerts on the hottest stocks on the Nasdaq/NYSE subscribe to our newsletter at TheStockExpert.com.
LGCY: 1.67 (-0.06), AMRS: 0.34 (-0.01), SRPT: 25.91 (+0.63), ORIG: 1.80 (-0.15)

Amyris Signs Five Year Biofene(R) Supply Agreement with leading Global Nutraceuticals Company with Over $100 Million of Expected Value
GlobeNewswire - Wed Apr 27, 7:30AM CDT
Amyris, Inc. (Nasdaq:AMRS), the industrial bioscience company, today announced that it has executed a five year Biofene supply agreement with a global nutraceuticals company. This new, long-term agreement replaces the parties' one-year purchase agreement, which was previously announced on January 4, 2016. Under the new supply agreement, the customer has agreed to a larger Biofene purchase in 2016 with an expected revenue contribution of approximately $9 million and to minimum annual purchase commitments in each of the remaining years of the agreement. In addition, under the new agreement, Amyris is entitled to a quarterly value-share arrangement on the sales of the customer's product made from the purchased Biofene. Amyris expects total revenue from the five-year agreement to be more than $100 million. In year-five of the supply agreement term, the agreement is projected to generate approximately $40 million of annual revenue, which Amyris expects will be renewed at that level in subsequent years.
AMRS: 0.34 (-0.01)

Amyris Named Gold 2016 Edison Award Winner -- One of Highest Accolades for Innovation in Business
GlobeNewswire - Mon Apr 25, 7:36AM CDT
Amyris, Inc. (Nasdaq:AMRS), the industrial bioscience company, is pleased to announce it has been named a Gold Edison Award winner for its collaborative development work on production of artemisinin for life-saving artemisinin combination therapies (ACTs), the World Health Organization's recommended first-line treatment for malaria. The Edison Awards, named after inventor Thomas Edison, are among the most prestigious accolades a company can receive and honor new product and service development, marketing, human-centered design and innovation that are considered "game-changing."
AMRS: 0.34 (-0.01)

Amyris Creates Program to Reduce the Cost and Increase Access to Leading Malaria Treatment
GlobeNewswire - Mon Apr 11, 10:00AM CDT
Amyris, Inc. (Nasdaq:AMRS), the industrial bioscience company, today announced the signing of a stock purchase agreement for a $5-million equity investment from the Bill & Melinda Gates Foundation. The investment is to fund a program to further reduce the cost of one of the world's leading malaria treatments so that no child has to go without treatment for malaria. The program will focus on the continued production of high-quality and secure supplies of artemisinic acid and amorphadiene to be converted to artemisinin for use in artemisinin combination therapies ("ACTs". ACTs are recommended by the World Health Organization ("WHO" as the primary first-line treatment for malaria.
AMRS: 0.34 (-0.01)

Amyris (AMRS) Catches Eye: Stock Moves 8.7% Higher
Zacks Equity Research - Zacks Investment Research - Mon Mar 28, 7:40AM CDT
Amyris, Inc. (AMRS) saw its shares rise above 8% in the last trading session.
EVA: 21.95 (+0.13), AMRS: 0.34 (-0.01)

Amyris Brotas Plant Sold Out for 2017-2020 Farnesene Volume - Project for Dedicated Flavors & Fragrances Initiated
GlobeNewswire - Mon Mar 21, 7:30AM CDT
Amyris, Inc. (Nasdaq:AMRS), the industrial bioscience company, today announced an expansion project to add a dedicated flavors & fragrances manufacturing unit to its Brotas industrial fermentation complex in Brazil. This planned expansion enables the company to meet demand for contracted flavors and fragrances molecules for its collaboration partners.
AMRS: 0.34 (-0.01)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Highway 99 Truck Death Puts Safety Records in Focus

Updated Category News Views 72

A stopped car on a highway shoulder is supposed to be a bad day, not a death sentence. Yet on November 5, 2026, a person helping a relative with a disabled vehicle was killed on northbound Highway 99 in Elk Grove after a commercial tractor-trailer allegedly drifted onto the shoulder, hit both stationary vehicles, and overturned. Northbound lanes were closed for hours. A...

Continue Reading
Leatt Sets Its Virtual 2026 Shareholder Meeting Date

Updated Category News Views 73

A calendar notice is not a catalyst, but ignoring the calendar is how shareholders miss the small moments that matter. Leatt Corporation has scheduled its 2026 virtual annual general meeting of stockholders for Friday, November 20, at 11:00 AM Eastern Time. For holders of OTCQB:LEAT, this is a basic corporate-governance event, not a new product launch or a financial...

Continue Reading
Roland DG's Brand Refresh Earns Three B2B Awards in 2026

Updated Category News Views 98

Three trophies for a printer-maker’s marketing overhaul will not move mountains by themselves, but they do tell us Roland DG has stopped treating its brand like an afterthought. The company’s global Make Your Mark refresh picked up two Silver awards and one Bronze at the 2026 Drum B2B Awards in Miami. For a business selling industrial-grade tools into crowded,...

Continue Reading
Devicie Broadens Browser Security Across Device Fleets

Updated Category News Views 57

Browsers have quietly become the front door, side door, and occasionally the busted basement window of corporate security. Devicie’s newly expanded Edge for Business Reporting Connector tackles that uncomfortable reality by pulling browser security events from Windows, macOS, iOS, and Android into the same console customers use to oversee Microsoft Intune environments....

Continue Reading
BKV Energy's $400,000 Loyalty Bet Has a Real Point Behind It

Updated Category News Views 92

Retail power customers rarely send thank-you notes; they switch plans, complain about bills, or quietly vanish. That is why BKV Energy putting more than $400,000 into its third annual ElectroShare payout deserves a harder look than the usual feel-good loyalty announcement. A Retention Expense With Some Teeth The payout has climbed quickly: roughly $113,000 in the first...

Continue Reading
MetaOptics Tests a Real Path Into Secure Imaging Markets

Updated Category News Views 77

Fingerprint scanners have never impressed me much; fooling one is exactly the sort of nuisance that keeps security buyers spending. MetaOptics’ new collaboration with Hong Kong’s ASTRI goes after that uncomfortable problem with a compact nano-optics imaging system built for biometric security and smart sensing. It is a sensible target. It is also, at this stage, a...

Continue Reading
Sinopec’s Algerian Outreach Reveals a Patient Long Game

Updated Category News Views 109

Soft Power Does Not Run a Refinery, but It Matters A short video contest in Algiers will not move an oilfield schedule or settle a hydrocarbons negotiation. That is precisely why this Sinopec-backed event deserves a sober look rather than a chest-thumping one. On Nov. 15, Sinopec Group and the Chinese Embassy in Algeria co-hosted the final of their second youth cultural...

Continue Reading
Freedom Debt Relief Earns Service Recognition in 2026

Updated Category News Views 48

A Service Badge Carries Weight in a Rough Business Debt settlement is not a business where a pleasant phone voice alone gets the job done. People arrive carrying unsecured balances, anxiety, and usually a fair amount of distrust. That is why CNBC Select naming Freedom Debt Relief its “Best for Customer Service” is more meaningful than the usual chest-thumping...

Continue Reading
Century Complete Tests Conway Demand Near Myrtle Beach

Updated Category News Views 96

Ninety-four lots in Conway may not move Wall Street by themselves, but they can say plenty about the kind of buyer Century Communities is chasing. Century Complete is opening its model at Cates Bay Crossing on Nov. 21, 2026, with single-family homes starting in the $260s. In a housing market where affordability gets talked to death and rarely delivered cleanly, that...

Continue Reading
DigiKey’s Arduino Webinar Puts Edge AI Hardware to Work

Updated Category News Views 87

A Small Board With a Big Practical Question Edge AI is finally getting dragged out of the slide deck and onto the workbench, which is where it ought to prove itself. DigiKey plans to host a free 60-minute webinar on Dec. 2, 2026, at 10 a.m. CST covering Arduino’s new VENTUNO Q edge AI computer. The session promises a hardware tour, an Arduino App Lab walkthrough, and a...

Continue Reading

Top 5 Most Recently Viewed Articles

Jordyn Poulter Shines in Times Square After Olympic Success

Updated Category News Views 419

Jordyn Poulter Shines in Times Square After Olympic Success Attention volleyball fans and supporters of women's sports: professional women's volleyball has officially made its mark in the United States. Today, a stunning billboard featuring Olympic silver medalist Jordyn Poulter was unveiled in the bustling Times Square of New York City. Poulter previously played for UYBA...

Continue Reading
Lifecore Biomedical Plans Exciting Financial Update Soon

Updated Category News Views 260

Lifecore Biomedical Prepares to Share Financial Insights Lifecore Biomedical, Inc. (NASDAQ: LFCR) is gearing up to share its financial outcomes for the second quarter of fiscal year 2025 in early January. This exciting announcement marks a significant moment for the company, which is known for its expertise in the contract development and manufacturing landscape. What to...

Continue Reading
Peloton Interactive, Inc. Sets Earnings Call for Q1 of 2025

Updated Category News Views 86

Peloton Interactive, Inc. Earnings Call Announcement Peloton Interactive, Inc. (NASDAQ: PTON) is gearing up for an important announcement regarding its financial results. The company will share its first quarter fiscal 2025 results before the stock market opens on a Thursday in late October. This is a key moment for both the company and its investors, as it lays out the...

Continue Reading
Centerspace Boosts Core FFO Guidance Amid Market Challenges

Updated Category News Views 159

Centerspace's Successful Third Quarter Performance Centerspace (NYSE: CSR), a prominent real estate investment trust, reported a strong third quarter performance in 2024 during its recent earnings call. The company announced a core funds from operations (FFO) of $1.18 per share, reflecting a notable 3% rise in same-store revenue, alongside an improved occupancy rate of...

Continue Reading
Ammunition Depot Crowned as Leading Online Ammo Retailer

Updated Category News Views 277

Ammunition Depot Crowned as Leading Online Ammo Retailer Ammunition Depot has been recognized as the best online destination for purchasing ammunition, according to a recent feature in Guns & Ammo Magazine. This accolade highlights their dedication to delivering a remarkable customer experience complemented by fast shipping and extensive product offerings. In a detailed...

Continue Reading